Heart Transplant Global Market Report 2025

Description

A heart transplant is a sophisticated surgical procedure in which a damaged or diseased heart is removed and replaced with a healthy donor heart. This intervention is crucial and can be life-saving for individuals suffering from end-stage heart failure or specific severe heart conditions.

There are several types of heart transplant surgeries, including total artificial heart, biventricular pacing, ventricular assist devices, and other specialized procedures. A total artificial heart is a mechanical device specifically engineered to take over the functions of both the left and right ventricles of the natural human heart. This category encompasses various transplant techniques like autografts, allografts, and others. The primary recipients of these procedures are hospitals, cardiac institutes, and other specialized medical facilities.

The heart transplant market research report is one of a series of new reports from The Business Research Company that provides heart transplant market statistics, including heart transplant industry global market size, regional shares, competitors with a heart transplant market share, detailed heart transplant market segments, market trends and opportunities and any further data you may need to thrive in the heart transplant industry. This heart transplant market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart transplant market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $12.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.

The heart transplant market size is expected to see strong growth in the next few years. It will grow to $18.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (AI) in donor organ selection.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the heart transplant market in the coming years. Cardiovascular diseases encompass a range of conditions that affect the heart and blood vessels. A heart transplant is a treatment of last resort for individuals with end-stage heart failure who have not responded to other therapies. It significantly improves the quality of life and extends life expectancy. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to increase by 1 million by 2030 and could rise by an additional 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases will drive the heart transplant market.

The heart transplant market is experiencing growth driven by an increased awareness of organ donation and transplantation. This awareness encompasses knowledge, understanding, and community consciousness regarding the processes, significance, and impact of these procedures in healthcare. This heightened awareness is playing a substantial role in the realm of heart transplants, leading to an expanded donor pool, reduced waiting times for recipients, and improved patient outcomes. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit organization focused on science and education, reported a record of 42,887 organ transplants in the US in 2022, marking a 3.7% increase from the previous year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants, underscoring the impact of this growing awareness. Consequently, the surge in awareness about organ donation and transplantation is a key driver for the heart transplant market.year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplant. Therefore, the growing awareness about organ donation and transplantation will drive the heart transplant market.

Major companies in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to enhance patient outcomes and improve transplant success rates. This technology significantly extends the preservation time of the heart outside the body compared to traditional ice storage, leading to better outcomes and reduced complications after transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) application for heart preservation technology. This approval enabled the company to launch the "PRESERVE Clinical Trial," a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, including those from Donation after Circulatory Death (DCD). The key feature of Xvivo's heart preservation technology is its non-ischemic hypothermic perfusion system, which uses cold, oxygenated perfusion to preserve donor hearts during transport.

In August 2024, Getinge, a Sweden-based company specializing in medical technology and healthcare solutions, acquired Paragonix Technologies for an undisclosed amount. This acquisition allows Getinge to strengthen its capabilities in organ preservation and transportation, with a focus on improving patient outcomes in transplant procedures. Paragonix Technologies, a U.S.-based company, designs, manufactures, and sells devices used for the transport of organs for transplant.

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heart transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart transplant market includes revenues earned by entities by providing services such as patient evaluation and selection, waitlist management, donor heart procurement, transplant surgery, immunosuppression management, psychosocial support and complications management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heart transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart transplant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types
2) By Transplant: Autograft; Allograft; Other Transplants
3) By End-User: Hospitals; Cardiac Institutes; Other End-Users
Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant
Companies Mentioned: Optum Inc.; Novartis Pharmaceuticals UK Ltd.; Abbott Laboratories; Medtronic plc; Stryker Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28232

1. Executive Summary

2. Heart Transplant Market Characteristics

3. Heart Transplant Market Trends And Strategies

4. Heart Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Heart Transplant Growth Analysis And Strategic Analysis Framework

5.1. Global Heart Transplant PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Heart Transplant Market Growth Rate Analysis
5.4. Global Heart Transplant Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Heart Transplant Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Heart Transplant Total Addressable Market (TAM)

6. Heart Transplant Market Segmentation

6.1. Global Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Artificial Heart
Biventricular Pacing
Ventricular Assist Devices
Other Surgery Types
6.2. Global Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autograft
Allograft
Other Transplants
6.3. Global Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cardiac Institutes
Other End-Users
6.4. Global Heart Transplant Market, Sub-Segmentation Of Total Artificial Heartl, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Temporary Total Artificial Heart
Permanent Total Artificial Heart
6.5. Global Heart Transplant Market, Sub-Segmentation Of Biventricular Pacing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
6.6. Global Heart Transplant Market, Sub-Segmentation Of Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
6.7. Global Heart Transplant Market, Sub-Segmentation Of Other Surgery Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart And Lung Transplant
Heterotopic Heart Transplant

7. Heart Transplant Market Regional And Country Analysis

7.1. Global Heart Transplant Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Heart Transplant Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Heart Transplant Market

8.1. Asia-Pacific Heart Transplant Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Heart Transplant Market

9.1. China Heart Transplant Market Overview
9.2. China Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Heart Transplant Market

10.1. India Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Heart Transplant Market

11.1. Japan Heart Transplant Market Overview
11.2. Japan Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Heart Transplant Market

12.1. Australia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Heart Transplant Market

13.1. Indonesia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Heart Transplant Market

14.1. South Korea Heart Transplant Market Overview
14.2. South Korea Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Heart Transplant Market

15.1. Western Europe Heart Transplant Market Overview
15.2. Western Europe Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Heart Transplant Market

16.1. UK Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Heart Transplant Market

17.1. Germany Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Heart Transplant Market

18.1. France Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Heart Transplant Market

19.1. Italy Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Heart Transplant Market

20.1. Spain Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Heart Transplant Market

21.1. Eastern Europe Heart Transplant Market Overview
21.2. Eastern Europe Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Heart Transplant Market

22.1. Russia Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Heart Transplant Market

23.1. North America Heart Transplant Market Overview
23.2. North America Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Heart Transplant Market

24.1. USA Heart Transplant Market Overview
24.2. USA Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Heart Transplant Market

25.1. Canada Heart Transplant Market Overview
25.2. Canada Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Heart Transplant Market

26.1. South America Heart Transplant Market Overview
26.2. South America Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Heart Transplant Market

27.1. Brazil Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Heart Transplant Market

28.1. Middle East Heart Transplant Market Overview
28.2. Middle East Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Heart Transplant Market

29.1. Africa Heart Transplant Market Overview
29.2. Africa Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Heart Transplant Market Competitive Landscape And Company Profiles

30.1. Heart Transplant Market Competitive Landscape
30.2. Heart Transplant Market Company Profiles
- 30.2.1. Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis Pharmaceuticals UK Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Heart Transplant Market Other Major And Innovative Companies

31.1. Roche Diagnostics Ltd.
31.2. Mayo Clinic
31.3. Cleveland Clinic
31.4. AstraZeneca plc
31.5. Massachusetts General Hospital
31.6. Terumo Corp.
31.7. NewYork-Presbyterian Hospital
31.8. Cedars-Sinai Medical Center
31.9. Maquet Holding B.V. and Co. KG.
31.10. Teleflex Inc.
31.11. Stanford Health Care
31.12. Johns Hopkins Hospital
31.13. Thoratec Corporation
31.14. Abiomed Inc.
31.15. Baylor St. Lukes Medical Center

32. Global Heart Transplant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Transplant Market

34. Recent Developments In The Heart Transplant Market

35. Heart Transplant Market High Potential Countries, Segments and Strategies

35.1 Heart Transplant Market In 2029 - Countries Offering Most New Opportunities
35.2 Heart Transplant Market In 2029 - Segments Offering Most New Opportunities
35.3 Heart Transplant Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer